Biopsy Devices Market Report
First published: 12 October 2024 | Last updated: 25 May 2026 | Report Code: biopsy-devices
Biopsy Devices Market — USD 8.4 billion in 2023, Growing to USD 14.10B by 2033 at 5.2% CAGR
This report provides a comprehensive analysis of the biopsy devices market, which encompasses size estimates, trends, opportunities, and competitive landscape from 2023 to 2033.
Key Takeaways
- Global market expands from $8.40 Billion in 2023 to $14.10 Billion by 2033 at a 5.2% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe grows from $2.76 Billion in 2023 to $4.63 Billion in 2033, reflecting sustained demand for diagnostic procedures.
- Asia Pacific is projected to move from $1.52 Billion to $2.55 Billion as minimally invasive techniques and imaging spread.
- Key vendors include Thermo Fisher Scientific Inc., Danaher Corporation, Boston Scientific Corporation, and Becton, Dickinson and Company.
Biopsy Devices Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The biopsy devices market is forecasted to grow from $8.40 Billion in 2023 to $14.10 Billion by 2033 at a 5.2% CAGR. Growth is driven by rising incidence of chronic and oncological conditions, advances in imaging and device automation, and increasing preference for minimally invasive diagnostics. The market structure spans device types such as needle, surgical, and endoscopic biopsies, technologies including image-guided and robotic-assisted systems, and end users like hospitals, diagnostic laboratories, and academic institutions. Regional performance varies, with North America holding the largest share. Manufacturers are concentrating on product innovation and strategic collaborations to address clinical needs and regulatory expectations. The report integrates primary interviews, secondary sources, and expert-led analysis to present an evidence-based view of market dynamics, adoption patterns, and competitive activity among leading firms.
Key Growth Drivers
- Rising prevalence of cancer and chronic diseases fueling demand for diagnostic tissue sampling.
- Advances in imaging and guidance systems improving precision and widening clinical adoption.
- Preference for minimally invasive procedures reducing patient recovery times and increasing procedure volume.
- Ongoing product innovation and strategic partnerships among major suppliers supporting market expansion.
- Growing investment in molecular pathology and automation enhancing diagnostic throughput and accuracy.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $8.40 Billion |
| CAGR (2023-2033) | 5.2% |
| 2033 Market Size | $14.10 Billion |
| Top Companies | Thermo Fisher Scientific Inc., Danaher Corporation, Boston Scientific Corporation, Becton, Dickinson and Company |
| Published Date | 12 October 2024 |
| Last Modified Date | 25 May 2026 |
Biopsy Devices Market Overview
Customize Biopsy Devices Market Report market research report
- ✔ Get in-depth analysis of Biopsy Devices market size, growth, and forecasts.
- ✔ Understand Biopsy Devices's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Biopsy Devices
What is the Market Size & CAGR of Biopsy Devices Market Report market in 2023?
Biopsy Devices Industry Analysis
Biopsy Devices Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Biopsy Devices Market Report Market Analysis Report by Region
Europe Biopsy Devices Market Report:
Europe grows from $2.76 Billion in 2023 to $4.63 Billion in 2033. 76 Billion in 2023 to $4.63 Billion in 2033, supported by growing demand for precise diagnostics, investments in minimally invasive techniques, and active clinical research and pathology services across multiple countries.Asia Pacific Biopsy Devices Market Report:
Asia Pacific grows from $1.52 Billion in 2023 to $2.55 Billion in 2033. 52 Billion in 2023 to $2.55 Billion in 2033, driven by expanding healthcare access, wider uptake of imaging technologies, and rising awareness of oncological diagnostics in emerging and established markets.North America Biopsy Devices Market Report:
North America is largest regional market, rising from $2.9 Billion in 2023 to $4.86 Billion in 2033. Regional momentum reflects advanced healthcare infrastructure, high procedure volumes, and early adoption of image-guided and robotic-assisted biopsy technologies.South America Biopsy Devices Market Report:
Latin America grows from $0.83 Billion in 2023 to $1.39 Billion in 2033. 83 Billion in 2023 to $1.39 Billion in 2033, with improved diagnostic infrastructure, greater access to minimally invasive procedures, and gradual adoption of newer biopsy technologies contributing to market development.Middle East & Africa Biopsy Devices Market Report:
Middle East and Africa grows from $0.4 Billion in 2023 to $0.66 Billion in 2033. 4 Billion in 2023 to $0.66 Billion in 2033, reflecting incremental investment in clinical facilities, growing diagnostic capacity, and expanded use of standardized biopsy procedures in select healthcare centers.Tell us your focus area and get a customized research report.
Research Methodology
Biopsy Devices Market Analysis By Device Type
In 2023, the needle biopsy segment was valued at $5.16 billion, accounting for 61.39% market share, and is expected to grow to $8.66 billion by 2033. Surgical biopsy follows with $1.86 billion in 2023, expected to reach $3.12 billion by 2033. Endoscopic biopsy is also growing from $1.38 billion to $2.32 billion over the same period.
Biopsy Devices Market Analysis By Technology
Image-guided biopsy, representing 61.39% share in 2023 with a market size of $5.16 billion, is anticipated to grow to $8.66 billion by 2033. Robotic-assisted biopsy, accounting for about 22.16% share with a market value of $1.86 billion, is expected to reach $3.12 billion by 2033, representing a significant technological advancement in the sector.
Biopsy Devices Market Analysis By End User
Hospitals dominate the end-user segment, holding a market size of $5.16 billion in 2023, projected to grow to $8.66 billion by 2033, accounting for 61.39% market share. Diagnostic laboratories and academic institutions follow, expected to grow from $1.86 billion to $3.12 billion and $1.38 billion to $2.32 billion respectively.
Biopsy Devices Market Analysis By Application
Oncology is the leading application area, with market sizes of $4.34 billion in 2023 expected to increase to $7.29 billion by 2033, representing a 51.68% share. The cardiology market is also vital, growing from $2.06 billion to $3.46 billion in the same period.
Biopsy Devices Market Analysis By Region
Global Biopsy Devices Market, By Region Market Analysis (2023 - 2033)
Regional analysis shows that North America holds the largest market share due to advanced healthcare systems, while Asia Pacific is growing rapidly due to increasing healthcare investments. Europe presents substantial growth opportunities with high R&D expenditure, while Latin America focuses on enhancing healthcare access.
Biopsy Devices Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Biopsy Devices Industry
Thermo Fisher Scientific Inc.:
A leading provider of innovative diagnostic solutions, they are committed to advancing the healthcare landscape through research and development.Danaher Corporation:
Known for its precision instruments, Danaher's technologies improve the quality of biopsies through analytical advancements.Boston Scientific Corporation:
A global leader in medical devices, Boston Scientific offers diverse biopsy solutions and actively invests in R&D.Becton, Dickinson and Company:
BD is highly regarded for its biopsy needles and related products, known for their quality and performance in diagnostics.We're grateful to work with incredible clients.
FAQs
What is the market size of the biopsy devices market in 2023?
The market size in 2023 is $8.40 Billion as stated in the report, reflecting current global demand for tissue-sampling technologies and related clinical services.
How big will the market be in 2033?
By 2033 the market is projected to reach $14.10 Billion, based on the forecast period and expected adoption of advanced biopsy technologies.
What is CAGR for the forecast period?
The compound annual growth rate (CAGR) for the 2023 to 2033 forecast period is 5.2%, indicating steady expansion across regions and segments.
Is there a single fastest Growing region in the Biopsy Devices Market Report market?
No single fastest-growing region is stated for the Biopsy Devices Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Why are minimally invasive procedures driving market growth?
Minimally invasive approaches reduce recovery time and complications, increasing procedure volumes and clinician preference, which supports broader uptake of biopsy devices.
Who are the leading companies in this market?
Top companies named include Thermo Fisher Scientific Inc., Danaher Corporation, Boston Scientific Corporation, and Becton, Dickinson and Company.
What end users utilize biopsy devices most?
Primary end users listed are hospitals, diagnostic laboratories, and academic institutions, which perform the majority of tissue-sampling procedures.
How are technological advances impacting the market?
Innovations such as image guidance and robotic assistance are improving diagnostic accuracy and procedural efficiency, contributing to increased market adoption.